GMP細胞治療用消耗品の世界市場レポート 2025年

GMP細胞治療用消耗品市場規模は、今後数年で飛躍的な成長が見込まれます。2029年にはCAGR26.7％で590億米ドルに成長します。予測期間の成長は、細胞治療アプリケーションの拡大、細胞治療試験の世界の増加、細胞治療に対する規制当局の支援、先進的細胞治療プラットフォームの出現、細胞治療製造の世界化などに起因すると考えられます。予測期間における主な動向としては、製造インフラへの投資、細胞加工における技術革新、共同研究やパートナーシップ、デジタル化とデータ統合、戦略的提携や合併などが挙げられます。

GMP細胞治療用消耗品市場の成長は、創薬への注目の高まりによって促進されると予測されます。創薬には、計算モデル、実験モデル、トランスレーショナルモデル、臨床モデルの統合による潜在的な新薬の同定が含まれます。分子生物学、遺伝学、バイオインフォマティクス、ハイスループットスクリーニングの技術的進歩は、創薬プロセスを大幅に強化しました。これらの進歩により、科学者たちは病気のメカニズムをより深く理解し、潜在的な創薬標的を特定し、大量の化合物ライブラリーを効率的にスクリーニングして潜在的な創薬候補を探し出すことができるようになった。特に、米国食品医薬品局（FDA）は、医薬品評価研究センター（CDER）が2022年に37の新薬および治療用生物学的製剤をさまざまな適応症で承認したことを報告しており、創薬の急増とそれがGMP細胞治療用消耗品市場に与える影響を浮き彫りにしています。

慢性疾患の有病率の増加は、GMP細胞治療用消耗品市場の成長を促進すると予想されます。慢性疾患は3ヵ月以上持続し、時間の経過とともに悪化する可能性があることが特徴であり、このような持続的な状態に対処するための革新的な細胞療法の研究開発が強化されています。様々な慢性疾患における細胞治療の適用拡大により、臨床試験の品質を確保するためのGMP消耗品に対する需要が高まっています。また、慢性疾患患者数の増加（National Center for Biotechnology Informationによると、2050年までに全世界で1億4,266万人に達すると予測されている）を背景に、厳しい規制遵守と革新的治療に対する需要の高まりが、市場の成長にさらに寄与しています。まとめると、慢性疾患の有病率の増加がGMP細胞治療用消耗品市場の重要な促進要因となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界GMP細胞治療用消耗品 PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界のGMP細胞治療用消耗品市場：成長率分析
• 世界のGMP細胞治療用消耗品市場の実績：規模と成長, 2019-2024
• 世界のGMP細胞治療用消耗品市場の予測：規模と成長, 2024-2029, 2034F
• 世界GMP細胞治療用消耗品総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のGMP細胞治療用消耗品市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• キット
• 試薬または分子生物学試薬
• 成長因子またはサイトカインとインターロイキン
• その他の製品
• 世界のGMP細胞治療用消耗品市場細胞療法による、実績と予測, 2019-2024, 2024-2029F, 2034F
• NK細胞療法
• 幹細胞療法
• T細胞療法
• その他の細胞療法
• 世界のGMP細胞治療用消耗品市場：プロセス別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 細胞の収集と特性評価または分類と分離
• 細胞培養と増殖または調製
• 凍結保存
• 細胞処理と製剤
• 細胞の分離と活性化
• 細胞の分配または取り扱い
• プロセスの監視と制御または再管理または品質保証
• その他のプロセス
• 世界のGMP細胞治療用消耗品市場：最終用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 臨床
• 商業用
• 調査
• 世界のGMP細胞治療用消耗品市場、キットのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 細胞培養キット
• 細胞分離キット
• トランスフェクションキット
• 世界のGMP細胞治療用消耗品市場、試薬または分子生物学試薬の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• バッファーとソリューション
• 酵素
• 染色試薬
• 世界のGMP細胞治療用消耗品市場、成長因子またはサイトカインとインターロイキンの種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 造血成長因子
• 抗体サイトカイン
• 免疫調節性サイトカイン
• 世界のGMP細胞治療用消耗品市場、その他の製品のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 細胞培養容器
• バイオリアクター
• メディアとサプリメント

第7章 地域別・国別分析

• 世界のGMP細胞治療用消耗品市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のGMP細胞治療用消耗品市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• GMP細胞治療用消耗品市場：競合情勢
• GMP細胞治療用消耗品市場：企業プロファイル
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Fresenius Kabi AG Overview, Products and Services, Strategy and Financial Analysis
  • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • Asahi Kasei Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• GE HealthCare Technologies Inc.
• Corning Incorporated
• Avantor Inc.
• Lonza Group AG
• Terumo Corporation
• Catalent Inc.
• Sartorius AG
• Bio-Techne Corp
• Repligen Corporation
• Miltenyi Biotec BV & Co KG
• Genscript Biotech Corporation
• Rentschler Biopharma SE
• FUJIFILM Irvine Scientific Inc.
• BioLegend Inc.
• STEMCELL Technologies Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• GMP細胞治療用消耗品市場2029：新たな機会を提供する国
• GMP細胞治療用消耗品市場2029：新たな機会を提供するセグメント
• GMP細胞治療用消耗品市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

GMP cell therapy consumables encompass consumable products and items manufactured in accordance with good manufacturing practices (GMP) guidelines for cell-based therapies. These consumables and tools designed for cell culture assist researchers in cultivating new cells in culture media, catering to various applications such as gene therapy, vaccine production, tissue culture, toxicity testing, and drug development.

The primary categories of GMP cell therapy consumables include kits, reagents or molecular biology reagents, growth factors or cytokines and interleukins, and other essential components. A kit is a compilation of items, such as tools or equipment, intended for a specific activity or purpose. In the realm of GMP cell therapy consumables, kits are utilized for tasks such as the isolation, expansion, harvesting, and formulation of cell therapies. These therapies encompass NK cell therapy, stem cell therapy, T-cell therapy, and others, involving processes such as cell collection and characterization or sorting and separation, cell culture and expansion or preparation, cryopreservation, cell processing and formulation, cell isolation and activation, cell distribution or handling, process monitoring and control or re-administration or quality assurance, among others. GMP cell therapy consumables find application in clinical, commercial, and research settings.

The GMP cell therapy consumables market research report is one of a series of new reports from The Business Research Company that provides GMP cell therapy consumables market statistics, including the GMP cell therapy consumables industry's global market size, regional shares, competitors with a GMP cell therapy consumables market share, detailed GMP cell therapy consumables market segments, market trends, and opportunities, and any further data you may need to thrive in the GMP cell therapy consumables industry. This GMP cell therapy consumables market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The GMP cell therapy consumables market size has grown exponentially in recent years. It will grow from $17.85 billion in 2024 to $22.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.1%. The growth in the historic period can be attributed to growing investments in regenerative medicine, advancements in cell therapy research, clinical trials and approvals, increasing prevalence of chronic diseases, rising awareness of personalized medicine

The GMP cell therapy consumables market size is expected to see exponential growth in the next few years. It will grow to $59 billion in 2029 at a compound annual growth rate (CAGR) of 26.7%. The growth in the forecast period can be attributed to expansion of cell therapy applications, global increase in cell therapy trials, regulatory support for cell therapies, emergence of advanced cell therapy platforms, globalization of cell therapy manufacturing. Major trends in the forecast period include investments in manufacturing infrastructure, technological innovations in cell processing, collaborations and partnerships, digitalization and data integration, strategic alliances and mergers.

The growth of the GMP cell therapy consumables market is anticipated to be propelled by the increasing focus on drug discovery. Drug discovery involves the identification of potential new medicinal entities through the integration of computational, experimental, translational, and clinical models. Technological advancements in molecular biology, genetics, bioinformatics, and high-throughput screening have significantly enhanced the drug discovery process. These advancements empower scientists to gain a better understanding of disease mechanisms, identify potential drug targets, and efficiently screen large compound libraries for potential drug candidates. Notably, the Food and Drug Administration (FDA) reported the approval of 37 new drugs and therapeutic biological products by its Center for Drug Evaluation and Research (CDER) in the US in 2022 for various indications, highlighting the surge in drug discovery and its impact on the GMP cell therapy consumables market.

The increasing prevalence of chronic diseases is expected to drive the growth of the GMP cell therapy consumables market. Chronic diseases, characterized by lasting three months or more and potentially worsening over time, have led to intensified research and development efforts in innovative cell therapies to address these persistent conditions. The expansion of cell therapy applications across various chronic diseases has resulted in a heightened demand for GMP consumables to ensure the quality of clinical trials. Stringent regulatory compliance and the growing demand for innovative therapies, driven by the rising number of individuals with chronic diseases (projected to reach 142.66 million worldwide by 2050 according to the National Center for Biotechnology Information), further contribute to the market's growth. In summary, the increasing prevalence of chronic diseases is a significant driver of the GMP cell therapy consumables market.

Leading companies in the GMP cell therapy consumables market are focusing on the development of GMP-compliant CD34+ hematopoietic stem cells (HSCs) to enhance advanced therapies. These GMP-compliant CD34+ HSCs are a specific type of stem cell that expresses the CD34 marker on their surface and is produced following Good Manufacturing Practice (GMP) standards. For example, in April 2024, OrganaBio, a US-based pharmaceutical firm, introduced HematoPAC-HSC-CB-GMP, a readily available source of GMP-compliant CD34+ HSCs obtained from fresh human cord blood. Leveraging its extensive expertise in cell isolation and GMP manufacturing, OrganaBio is able to yield high quantities of highly viable CD34+ HSCs within 24 hours post-collection. This launch aims to support the advancement of next-generation therapies for blood cancers and genetic disorders.

Major companies in the GMP cell therapy consumables market are also concentrating on the development of cutting-edge products, such as cell isolation systems, to gain a competitive advantage. A cell isolation system is a technological platform or device designed to separate specific cells from a mixture based on criteria such as size, markers, or other characteristics. In January 2022, Sony Group Corporation, a Japan-based conglomerate, launched the CGX10 Cell Isolation System, featuring high-speed, high-purity cell sorting within a closed system. The closed structure ensures sterility, making it particularly suitable for applications such as cell-based immunotherapy, where maintaining a sterile environment is crucial. The system, equipped with up to ten parameters and four lasers, enables the isolation of cells with approximately 97% purity at a speed of 15,000 cells per second. The use of a single-use disposable tubing kit minimizes the risk of cross-contamination between samples, showcasing Sony's commitment to advancing cell therapy development and manufacturing.

In September 2022, Cellistic, a Belgium-based company specializing in cell therapies based on human induced pluripotent stem cell (iPSC) technology, acquired Celyad Oncology's GMP-grade cell therapy manufacturing facility for $7.46 million. This strategic acquisition positions Cellistic to leverage the acquired skills and assets, advancing the development of its unique platforms and enhancing the capacity to assist partners in delivering iPSC-based allogeneic cell therapies to patients more efficiently. Celyad Oncology, a renowned biotechnology firm based in Belgium, is dedicated to exploring and developing innovative chimeric antigen receptor (CAR) T-cell therapies designed specifically to combat cancer.

Major companies operating in the GMP cell therapy consumables market include Thermo Fisher Scientific Inc., Fresenius Kabi AG, Danaher Corporation, Merck KGaA, Asahi Kasei Corporation, GE HealthCare Technologies Inc., Corning Incorporated, Avantor Inc., Lonza Group AG, Terumo Corporation, Catalent Inc., Sartorius AG, Bio-Techne Corp, Repligen Corporation, Miltenyi Biotec BV & Co KG, Genscript Biotech Corporation, Rentschler Biopharma SE, FUJIFILM Irvine Scientific Inc., BioLegend Inc., STEMCELL Technologies Inc., BioLife Solutions Inc., Abzena Ltd., Sino Biological Inc., ProBioGen AG, MaxCyte Inc., PromoCell GmbH, PeproTech Inc., Cellares Corp., Wilson Wolf Corporation, Cellexus Ltd.

North America was the largest region in the GMP cell therapy consumables market in 2024. Asia-pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gmp cell therapy consumables market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the gmp cell therapy consumables market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The GMP cell therapy consumables market consists of sales of cell culture media, media supplements, extracellular matrices, flasks, tubes, dishes or cryovials, serological pipettes, or centrifugation tubes. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

GMP Cell Therapy Consumables Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on gmp cell therapy consumables market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for gmp cell therapy consumables ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The gmp cell therapy consumables market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Kits; Reagents Or Molecular Biology reagents; Growth Factors Or Cytokines And Interleukins; Other Products
• 2) By Cell Therapy: NK Cell Therapy; Stem Cell Therapy; T-Cell Therapy; Other cell therapies
• 3) By Process: Cell Collection And Characterization Or Sorting And Separation; Cell Culture And Expansion Or Preparation; Cryopreservation; Cell Processing And Formulation; Cell Isolation And Activation; Cell Distribution Or Handling; Process Monitoring And Control Or Readministration Or Quality Assurance; Other Processes
• 4) By End-Use: Clinical; Commercial; Research
• Subsegments:
• 1) By Kits: Cell Culture Kits; Cell Isolation Kits; Transfection Kits
• 2) By Reagents Or Molecular Biology Reagents: Buffers And Solutions; Enzymes; Staining Reagents
• 3) By Growth Factors Or Cytokines And Interleukins: Hematopoietic Growth Factors; Antibody Cytokines; Immunomodulatory Cytokines
• 3) By Other Products: Cell Culture Vessels; Bioreactors; Media And Supplements
• Companies Mentioned: Thermo Fisher Scientific Inc.; Fresenius Kabi AG; Danaher Corporation; Merck KGaA; Asahi Kasei Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. GMP Cell Therapy Consumables Market Characteristics

3. GMP Cell Therapy Consumables Market Trends And Strategies

4. GMP Cell Therapy Consumables Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global GMP Cell Therapy Consumables Growth Analysis And Strategic Analysis Framework

• 5.1. Global GMP Cell Therapy Consumables PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global GMP Cell Therapy Consumables Market Growth Rate Analysis
• 5.4. Global GMP Cell Therapy Consumables Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global GMP Cell Therapy Consumables Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global GMP Cell Therapy Consumables Total Addressable Market (TAM)

6. GMP Cell Therapy Consumables Market Segmentation

• 6.1. Global GMP Cell Therapy Consumables Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Kits
• Reagents or Molecular Biology Reagents
• Growth Factors or Cytokines and Interleukins
• Other Products
• 6.2. Global GMP Cell Therapy Consumables Market, Segmentation By Cell Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• NK Cell Therapy
• Stem Cell Therapy
• T-Cell Therapy
• Other Cell Therapies
• 6.3. Global GMP Cell Therapy Consumables Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cell Collection and Characterization or Sorting and Separation
• Cell Culture and Expansion or Preparation
• Cryopreservation
• Cell Processing and Formulation
• Cell Isolation and Activation
• Cell Distribution or Handling
• Process Monitoring and Control or Readministration or Quality Assurance
• Other Processes
• 6.4. Global GMP Cell Therapy Consumables Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Clinical
• Commercial
• Research
• 6.5. Global GMP Cell Therapy Consumables Market, Sub-Segmentation Of Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cell Culture Kits
• Cell Isolation Kits
• Transfection Kits
• 6.6. Global GMP Cell Therapy Consumables Market, Sub-Segmentation Of Reagents Or Molecular Biology Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Buffers And Solutions
• Enzymes
• Staining Reagents
• 6.7. Global GMP Cell Therapy Consumables Market, Sub-Segmentation Of Growth Factors Or Cytokines And Interleukins, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hematopoietic Growth Factors
• Antibody Cytokines
• Immunomodulatory Cytokines
• 6.8. Global GMP Cell Therapy Consumables Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cell Culture Vessels
• Bioreactors
• Media And Supplements

7. GMP Cell Therapy Consumables Market Regional And Country Analysis

• 7.1. Global GMP Cell Therapy Consumables Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global GMP Cell Therapy Consumables Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific GMP Cell Therapy Consumables Market

• 8.1. Asia-Pacific GMP Cell Therapy Consumables Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific GMP Cell Therapy Consumables Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific GMP Cell Therapy Consumables Market, Segmentation By Cell Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific GMP Cell Therapy Consumables Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China GMP Cell Therapy Consumables Market

• 9.1. China GMP Cell Therapy Consumables Market Overview
• 9.2. China GMP Cell Therapy Consumables Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China GMP Cell Therapy Consumables Market, Segmentation By Cell Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China GMP Cell Therapy Consumables Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India GMP Cell Therapy Consumables Market

• 10.1. India GMP Cell Therapy Consumables Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India GMP Cell Therapy Consumables Market, Segmentation By Cell Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India GMP Cell Therapy Consumables Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan GMP Cell Therapy Consumables Market

• 11.1. Japan GMP Cell Therapy Consumables Market Overview
• 11.2. Japan GMP Cell Therapy Consumables Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan GMP Cell Therapy Consumables Market, Segmentation By Cell Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan GMP Cell Therapy Consumables Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia GMP Cell Therapy Consumables Market

• 12.1. Australia GMP Cell Therapy Consumables Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia GMP Cell Therapy Consumables Market, Segmentation By Cell Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia GMP Cell Therapy Consumables Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia GMP Cell Therapy Consumables Market

• 13.1. Indonesia GMP Cell Therapy Consumables Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia GMP Cell Therapy Consumables Market, Segmentation By Cell Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia GMP Cell Therapy Consumables Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea GMP Cell Therapy Consumables Market

• 14.1. South Korea GMP Cell Therapy Consumables Market Overview
• 14.2. South Korea GMP Cell Therapy Consumables Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea GMP Cell Therapy Consumables Market, Segmentation By Cell Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea GMP Cell Therapy Consumables Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe GMP Cell Therapy Consumables Market

• 15.1. Western Europe GMP Cell Therapy Consumables Market Overview
• 15.2. Western Europe GMP Cell Therapy Consumables Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe GMP Cell Therapy Consumables Market, Segmentation By Cell Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe GMP Cell Therapy Consumables Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK GMP Cell Therapy Consumables Market

• 16.1. UK GMP Cell Therapy Consumables Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK GMP Cell Therapy Consumables Market, Segmentation By Cell Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK GMP Cell Therapy Consumables Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany GMP Cell Therapy Consumables Market

• 17.1. Germany GMP Cell Therapy Consumables Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany GMP Cell Therapy Consumables Market, Segmentation By Cell Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany GMP Cell Therapy Consumables Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France GMP Cell Therapy Consumables Market

• 18.1. France GMP Cell Therapy Consumables Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France GMP Cell Therapy Consumables Market, Segmentation By Cell Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France GMP Cell Therapy Consumables Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy GMP Cell Therapy Consumables Market

• 19.1. Italy GMP Cell Therapy Consumables Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy GMP Cell Therapy Consumables Market, Segmentation By Cell Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy GMP Cell Therapy Consumables Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain GMP Cell Therapy Consumables Market

• 20.1. Spain GMP Cell Therapy Consumables Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain GMP Cell Therapy Consumables Market, Segmentation By Cell Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain GMP Cell Therapy Consumables Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe GMP Cell Therapy Consumables Market

• 21.1. Eastern Europe GMP Cell Therapy Consumables Market Overview
• 21.2. Eastern Europe GMP Cell Therapy Consumables Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe GMP Cell Therapy Consumables Market, Segmentation By Cell Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe GMP Cell Therapy Consumables Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia GMP Cell Therapy Consumables Market

• 22.1. Russia GMP Cell Therapy Consumables Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia GMP Cell Therapy Consumables Market, Segmentation By Cell Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia GMP Cell Therapy Consumables Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America GMP Cell Therapy Consumables Market

• 23.1. North America GMP Cell Therapy Consumables Market Overview
• 23.2. North America GMP Cell Therapy Consumables Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America GMP Cell Therapy Consumables Market, Segmentation By Cell Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America GMP Cell Therapy Consumables Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA GMP Cell Therapy Consumables Market

• 24.1. USA GMP Cell Therapy Consumables Market Overview
• 24.2. USA GMP Cell Therapy Consumables Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA GMP Cell Therapy Consumables Market, Segmentation By Cell Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA GMP Cell Therapy Consumables Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada GMP Cell Therapy Consumables Market

• 25.1. Canada GMP Cell Therapy Consumables Market Overview
• 25.2. Canada GMP Cell Therapy Consumables Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada GMP Cell Therapy Consumables Market, Segmentation By Cell Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada GMP Cell Therapy Consumables Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America GMP Cell Therapy Consumables Market

• 26.1. South America GMP Cell Therapy Consumables Market Overview
• 26.2. South America GMP Cell Therapy Consumables Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America GMP Cell Therapy Consumables Market, Segmentation By Cell Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America GMP Cell Therapy Consumables Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil GMP Cell Therapy Consumables Market

• 27.1. Brazil GMP Cell Therapy Consumables Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil GMP Cell Therapy Consumables Market, Segmentation By Cell Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil GMP Cell Therapy Consumables Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East GMP Cell Therapy Consumables Market

• 28.1. Middle East GMP Cell Therapy Consumables Market Overview
• 28.2. Middle East GMP Cell Therapy Consumables Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East GMP Cell Therapy Consumables Market, Segmentation By Cell Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East GMP Cell Therapy Consumables Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa GMP Cell Therapy Consumables Market

• 29.1. Africa GMP Cell Therapy Consumables Market Overview
• 29.2. Africa GMP Cell Therapy Consumables Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa GMP Cell Therapy Consumables Market, Segmentation By Cell Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa GMP Cell Therapy Consumables Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. GMP Cell Therapy Consumables Market Competitive Landscape And Company Profiles

• 30.1. GMP Cell Therapy Consumables Market Competitive Landscape
• 30.2. GMP Cell Therapy Consumables Market Company Profiles
  • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Fresenius Kabi AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Asahi Kasei Corporation Overview, Products and Services, Strategy and Financial Analysis

31. GMP Cell Therapy Consumables Market Other Major And Innovative Companies

• 31.1. GE HealthCare Technologies Inc.
• 31.2. Corning Incorporated
• 31.3. Avantor Inc.
• 31.4. Lonza Group AG
• 31.5. Terumo Corporation
• 31.6. Catalent Inc.
• 31.7. Sartorius AG
• 31.8. Bio-Techne Corp
• 31.9. Repligen Corporation
• 31.10. Miltenyi Biotec BV & Co KG
• 31.11. Genscript Biotech Corporation
• 31.12. Rentschler Biopharma SE
• 31.13. FUJIFILM Irvine Scientific Inc.
• 31.14. BioLegend Inc.
• 31.15. STEMCELL Technologies Inc.

32. Global GMP Cell Therapy Consumables Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The GMP Cell Therapy Consumables Market

34. Recent Developments In The GMP Cell Therapy Consumables Market

35. GMP Cell Therapy Consumables Market High Potential Countries, Segments and Strategies

• 35.1 GMP Cell Therapy Consumables Market In 2029 - Countries Offering Most New Opportunities
• 35.2 GMP Cell Therapy Consumables Market In 2029 - Segments Offering Most New Opportunities
• 35.3 GMP Cell Therapy Consumables Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer